Rosacea is a chronic cutaneous disorder, which mainly affects the central areas of the face, with potential ocular involvement.1 It is characterised by frequent flushing, persistent erythema and telangiectasia, as well as inflammation, which may overlap with swelling, papules and pustules.2 There is some statistical variance reported within the literature regarding the prevalence of cases, but it is thought to affect up to 10% of the global population, with historical reporting largely centred around Fitzpatrick skin types I and II.3 Reduced vigilance and later presentation may account for some of the reasons why rosacea may be incorrectly diagnosed or historically unrecognised in skin of colour individuals.4 Delayed diagnosis can lead to greater morbidity and disease progression, which reinforces the importance of accurate and timely diagnosis and management in symptomatic individuals.5
